Surrogacy Guide

China imposes strict legal regulations on egg donation, explicitly prohibiting commercial egg donation. This article provides a detailed interpretation of the legal boundaries, legitimate pathways, and risks of egg donation in China from the perspectives of legal provisions, medical ethics, and clinical procedures, helping you accurately understand the relevant regulations.

PGT-A is a preimplantation genetic screening technology for aneuploidy, used to detect whether the number of chromosomes in an embryo is normal. This article systematically introduces the current application status of PGT-A technology in China from the aspects of technical principles, applicable populations, testing process, clinical value, and limitations, helping patients understand the true role and applicable conditions of this technology.

China's hysteroscopy technology has reached an advanced international level, widely used in infertility diagnosis, intrauterine lesion treatment, and pre-assisted reproductive assessment. This article objectively evaluates the true level of Chinese hysteroscopy from the perspectives of technological development, clinical application, equipment standards, and physician experience, helping patients understand the value and limitations of hysteroscopic examination and treatment.

Sperm donation is legal in China under strict regulations such as the Measures for the Administration of Human Sperm Banks. Donors must meet age, health, and genetic criteria, and the process is managed by authorized sperm banks. This article provides a comprehensive overview from legal basis, procedures, conditions, to common questions.

Egg retrieval in China typically uses intravenous anesthesia (painless egg retrieval). In some cases, local anesthesia or analgesia may be chosen. This article, explained in detail by a reproductive doctor, covers egg retrieval anesthesia methods, suitable candidates, procedures, and risks, helping you understand the real situation of egg retrieval anesthesia.

The annual number of non-local patients at Chinese assisted reproduction hospitals varies by region, tier, and specialty. Top fertility centers may see 60%-70% non-local patients, with annual visits ranging from thousands to tens of thousands. Based on industry observations, this article analyzes influencing factors, the treatment process, and provides practical advice to help inter-provincial patients plan their travel and costs effectively.

Non-invasive chromosomal screening (NIPT) in China covers major obstetrics and reproductive centers nationwide, with a detection rate for trisomy 21 exceeding 99%, but limitations such as false positives and insufficient fetal fraction exist. This article analyzes the technology principles, applicable populations, testing process, costs, and risks from a reproductive doctor's perspective to help patients rationally understand screening results.

Over 500 fertility centers approved by the National Health Commission in China, covering 31 provinces. This article provides technical grade classification, accreditation verification methods, differences between public and private centers, age-specific selection advice, and common misconceptions to help users make informed decisions.

The pain level of egg retrieval surgery is directly related to the anesthesia method. Currently, regular reproductive centers in China generally use intravenous anesthesia for egg retrieval, with patients feeling no pain during the procedure. In a few cases, local anesthesia or no anesthesia is used, which may cause discomfort similar to menstrual pain. This article explains the real situation of egg retrieval pain in detail from the perspectives of anesthesia methods, individual differences, and surgical procedures.

Ovulation induction drugs in China are generally safe when used under medical guidance, but risks such as ovarian hyperstimulation syndrome and multiple pregnancies exist. Ovulation induction drugs include letrozole, clomiphene, gonadotropins, etc., with different indications and risks. This article interprets the safety, suitable populations, medication process, and precautions of ovulation induction drugs from the perspective of a reproductive doctor.

Chinese doctor credentials can be verified through the National Health Commission official website, the Medical Administration and Medical Affairs Bureau platform, or the 'Healthy China' app. Enter the doctor's name and practice location to verify their practicing physician qualification, scope of practice, and affiliated medical institution. For doctors in assisted reproduction, additional verification of specific assisted reproductive technology qualifications and center approval status is required.

The proportion of Chinese patients in Thai assisted reproduction hospitals varies significantly depending on the hospital's market positioning, Chinese language service capabilities, and doctor reputation. Industry observations estimate the range from 10% to 80%. This article analyzes the proportion of Chinese patients in different Thai reproductive centers, influencing factors, and selection suggestions.

China's Assisted Reproductive Technology Regulations are mandatory industry standards formulated by the National Health Commission, covering technical operation requirements, institutional qualifications, indications and contraindications, embryo transfer limits, ethical norms, etc., for procedures such as IVF and artificial insemination. This article systematically interprets the core provisions and clinical application points to help patients and practitioners accurately understand the regulatory requirements.

Chinese hospital service attitudes vary by type, region, and department. Patients undergoing assisted reproduction need professional communication, emotional support, and process transparency. Based on real treatment experiences, this article analyzes service differences between public and private hospitals, offering evaluation methods and selection references to help patients set reasonable expectations and reduce treatment barriers.

PGT (Preimplantation Genetic Testing) can be used in China to screen for chromosomal numerical abnormalities and structural abnormalities, but there are technical boundaries to its detection range. This article, based on clinical practice, explains the detection capabilities, indications, limitations, and key decision points of PGT-A and PGT-SR.

To verify the official website address of an assisted reproduction hospital in China, you must check through the National Health Commission website, provincial health commission websites, or the China Assisted Reproductive Technology Management Information System. All over 500 approved fertility centers are registered. It is recommended to directly access official channels to obtain accurate URLs and avoid intermediary counterfeit websites. This article provides the official website verification process and validation methods.

Answers whether Georgian assisted reproduction hospitals have Chinese doctors, introduces the situation of some hospitals equipped with translators or Chinese consultants, analyzes the impact of language support on the medical process, and helps patients decide if they need a Chinese doctor.

The storage period for sperm cryopreservation in China is implemented according to the 'Technical Standards for Human Sperm Banks'. Autologous sperm preservation is routinely 5 years, renewable up to 10 years. Sperm cryopreservation recovery rate is related to pre-freeze semen quality, freezing technology, and storage conditions. Sperm can be stored long-term in a liquid nitrogen environment but is subject to regulatory constraints. This article, interpreted by a reproductive doctor, explains the storage period, procedures, and precautions.

Since the birth of the first test-tube baby at Peking University Third Hospital in 1988, China's assisted reproductive technology has gone through four stages: technology introduction, standardized management, independent innovation, and inclusive development. This article systematically reviews over 30 years of technological breakthroughs, policy evolution, and clinical application, covering the transition from first to third-generation IVF, differentiated development paths of reproductive centers, and industry trend observations.

A comprehensive guide to transportation routes and travel options for major IVF hospitals in China, covering metro, bus, self-driving, and accommodation for out-of-town patients. Helps patients plan their medical trips in advance and reduce travel stress.